IN2014MN02029A - - Google Patents

Info

Publication number
IN2014MN02029A
IN2014MN02029A IN2029MUN2014A IN2014MN02029A IN 2014MN02029 A IN2014MN02029 A IN 2014MN02029A IN 2029MUN2014 A IN2029MUN2014 A IN 2029MUN2014A IN 2014MN02029 A IN2014MN02029 A IN 2014MN02029A
Authority
IN
India
Prior art keywords
orally disintegrating
disintegrating tablet
33provided
palatable
mouth
Prior art date
Application number
Other languages
English (en)
Inventor
Gaku Sekiguchi
Ryoichi Hayakawa
Yoshihiro Hara
Original Assignee
Daiichi Sankyo Companyltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Companyltd filed Critical Daiichi Sankyo Companyltd
Publication of IN2014MN02029A publication Critical patent/IN2014MN02029A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2029MUN2014 2012-04-24 2013-04-23 IN2014MN02029A (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012098770 2012-04-24
PCT/JP2013/061936 WO2013161823A1 (ja) 2012-04-24 2013-04-23 口腔内崩壊錠及びその製造方法

Publications (1)

Publication Number Publication Date
IN2014MN02029A true IN2014MN02029A (enrdf_load_html_response) 2015-08-14

Family

ID=49483132

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2029MUN2014 IN2014MN02029A (enrdf_load_html_response) 2012-04-24 2013-04-23

Country Status (11)

Country Link
US (1) US9827200B2 (enrdf_load_html_response)
EP (1) EP2842549B1 (enrdf_load_html_response)
JP (4) JP6066351B2 (enrdf_load_html_response)
KR (1) KR101943686B1 (enrdf_load_html_response)
CN (2) CN106913553A (enrdf_load_html_response)
BR (1) BR112014026292B1 (enrdf_load_html_response)
CA (1) CA2870868C (enrdf_load_html_response)
ES (1) ES2694224T3 (enrdf_load_html_response)
IN (1) IN2014MN02029A (enrdf_load_html_response)
TW (1) TWI572371B (enrdf_load_html_response)
WO (1) WO2013161823A1 (enrdf_load_html_response)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2905019A1 (en) * 2014-02-05 2015-08-12 Sanovel Ilac Sanayi ve Ticaret A.S. Orally disintegrating tablet formulations of memantine
CA2962714C (en) * 2014-10-03 2023-09-19 Novartis Ag Pharmaceutical compositions comprising alpelisib
JP5827428B1 (ja) * 2015-01-15 2015-12-02 日新製薬株式会社 テルミサルタン含有錠剤
JP2016141630A (ja) * 2015-01-30 2016-08-08 富士フイルム株式会社 口腔内崩壊錠
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN108066304B (zh) * 2016-11-16 2022-09-16 深圳万和制药有限公司 具有缓释性能的坦索罗辛口腔崩解片组合物
TWI812602B (zh) * 2016-12-01 2023-08-21 日商第一三共股份有限公司 含二胺衍生物之口腔崩散錠及其製造方法
JP7009288B2 (ja) * 2017-05-18 2022-01-25 エルメッド株式会社 湿製錠剤の製造方法及び湿製錠剤の品質向上方法
JP7023186B2 (ja) * 2017-05-29 2022-02-21 第一三共株式会社 認知症治療薬を含有する口腔内崩壊性錠剤
JP7182356B2 (ja) * 2017-07-05 2022-12-02 日本ケミファ株式会社 口腔内崩壊錠及びその製造方法
JP7198575B2 (ja) * 2017-07-11 2023-01-04 キョーリンリメディオ株式会社 メマンチン塩酸塩含有口腔内崩壊錠
JP7148319B2 (ja) * 2017-08-17 2022-10-05 第一三共株式会社 プラスグレルを含む口腔内崩壊錠
TWI795462B (zh) 2017-11-17 2023-03-11 日商鹽野義製藥股份有限公司 光安定性及溶出性優異的醫藥製劑
JP7360949B2 (ja) * 2017-12-26 2023-10-13 東和薬品株式会社 環状口腔内崩壊錠
WO2019146642A1 (ja) * 2018-01-24 2019-08-01 大原薬品工業株式会社 γ－アミノ酪酸誘導体含有錠剤の化学的安定性を改善する方法
CN110613691A (zh) * 2018-06-19 2019-12-27 北京万全德众医药生物技术有限公司 一种含有peg-dspe-盐酸美金刚复合物的口崩片
TWI826474B (zh) 2018-06-27 2023-12-21 日商第一三共股份有限公司 包含二胺衍生物之顆粒劑、以及其用途及製造方法
JP2020105173A (ja) * 2018-12-27 2020-07-09 日本ケミファ株式会社 ２種以上の薬物を含有する口腔内崩壊錠及びその製造方法
CN109512790A (zh) * 2018-12-28 2019-03-26 金日制药（中国）有限公司 一种口腔崩解片的处方及制备工艺
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠
CN115701992A (zh) * 2020-07-03 2023-02-14 步制药股份有限公司 片剂及其制造方法
BR112023000403A2 (pt) * 2020-07-27 2023-02-07 Daiichi Sankyo Co Ltd Comprimido de desintegração oral, e, método para produzir um comprimido de desintegração oral
WO2022102457A1 (ja) * 2020-11-10 2022-05-19 沢井製薬株式会社 リナグリプチン含有口腔内崩壊錠
JP2022135317A (ja) * 2021-03-05 2022-09-15 日医工株式会社 リナグリプチン製剤
CN113181125B (zh) * 2021-04-27 2022-07-19 海南通用三洋药业有限公司 一种西他沙星片剂及其制备方法
CN113332252A (zh) * 2021-06-07 2021-09-03 大桐制药（中国）有限责任公司 一种洛索洛芬钠片的制备方法
CN113244238B (zh) * 2021-06-16 2022-05-20 北京斯利安药业有限公司 含盐酸苯海索和叶酸的口崩片及其制备方法
JP7210794B2 (ja) * 2021-06-16 2023-01-23 日本ジェネリック株式会社 リナグリプチン含有製剤及びリナグリプチン含有口腔内崩壊性錠剤

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH31467A (en) * 1994-01-31 1998-11-03 Yamanouchi Pharma Co Ltd Intrabucally dissolving compressed mouldings and production process thereof.
JP4438121B2 (ja) * 1998-04-27 2010-03-24 大正製薬株式会社 口腔内速崩錠及びその製造方法
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP4551627B2 (ja) * 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
JP5584509B2 (ja) * 2003-02-28 2014-09-03 東和薬品株式会社 口腔内崩壊錠剤
CA2529535A1 (en) * 2003-06-16 2004-12-29 Allergan, Inc. Memantine oral dosage forms
JP3841804B2 (ja) * 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
CN101420982B (zh) * 2006-04-13 2011-11-09 东亚药品株式会社 干式直压速崩片
JP5237098B2 (ja) * 2006-08-08 2013-07-17 キッセイ薬品工業株式会社 苦味をマスキングした口腔内崩壊錠、およびその製造方法
CN102006861B (zh) * 2008-02-13 2012-11-21 大日本住友制药株式会社 口腔崩解片
JP2010070466A (ja) * 2008-09-16 2010-04-02 Kyoto Pharmaceutical Industries Ltd 口腔内崩壊錠
JP5549443B2 (ja) 2009-07-15 2014-07-16 ライオン株式会社 口腔内崩壊錠及びその製造方法
CN104258408B (zh) * 2010-03-31 2017-10-03 持田制药株式会社 易服用性固体制剂
JP5680898B2 (ja) * 2010-08-10 2015-03-04 京都薬品工業株式会社 苦味を抑制した速崩壊錠
JP5956475B2 (ja) * 2012-02-03 2016-07-27 旭化成株式会社 苦味マスク顆粒含有口腔内崩壊錠

Also Published As

Publication number Publication date
TW201347792A (zh) 2013-12-01
US20150110880A1 (en) 2015-04-23
JP2018058910A (ja) 2018-04-12
CN106913553A (zh) 2017-07-04
KR20150003740A (ko) 2015-01-09
EP2842549B1 (en) 2018-08-08
CN104244930A (zh) 2014-12-24
US9827200B2 (en) 2017-11-28
BR112014026292A2 (pt) 2017-06-27
KR101943686B1 (ko) 2019-01-29
HK1206983A1 (en) 2016-01-22
JP6545839B2 (ja) 2019-07-17
JPWO2013161823A1 (ja) 2015-12-24
JP6325627B2 (ja) 2018-05-16
EP2842549A1 (en) 2015-03-04
EP2842549A4 (en) 2015-09-23
TWI572371B (zh) 2017-03-01
JP2017008112A (ja) 2017-01-12
WO2013161823A1 (ja) 2013-10-31
JP6066351B2 (ja) 2017-01-25
BR112014026292B1 (pt) 2022-09-27
JP2019151670A (ja) 2019-09-12
CA2870868C (en) 2018-02-20
JP7028829B2 (ja) 2022-03-02
CA2870868A1 (en) 2013-10-31
ES2694224T3 (es) 2018-12-19

Similar Documents

Publication Publication Date Title
IN2014MN02029A (enrdf_load_html_response)
USD748812S1 (en) Arched cell culture flask
MY162145A (en) Gel composition
MY164904A (en) Tobacco substrate
NZ602751A (en) Processing biomass
PH12013501222A1 (en) Soluble milk-based tablet surface-treated with carbohydrate
IN2014DE03239A (enrdf_load_html_response)
MX2010004889A (es) Suspension pediatrica estabilizada de carisbamato.
MX340592B (es) Proceso para la produccion de dioxido de cloro.
TN2012000507A1 (en) Enteric tablet
WO2013166131A3 (en) Orally disintegrating tablet
MX2010002506A (es) Compuestos de nicotinamida sustituidos y uso de estos en medicamentos.
MY169160A (en) Method for producing starch granules, and orally disintegrating tablet
WO2014006636A3 (en) Stable compositions of fesoterodine
MY161968A (en) Granules comprising pyrazosulfron ethyl and pretilachlor
PH12014501024A1 (en) Soluble non-dairy creamer tablet surface-treated with carbohydrate
GB201120492D0 (en) Food that is easy to chew and swallow, and process for production of the food
ZA201403543B (en) Process for the synthesis of 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
USD744838S1 (en) Container
MX2015012311A (es) Proceso para formar un articulo para el cuidado personal.
WO2012111961A3 (ko) 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
UA41304U (ru) Кристаллическая структура комбинированного лекарственного препарата валсартану с гидрохлортиазидом в форме таблеток
GEU20101592Y (en) Anber tablet
IN2014MU00665A (enrdf_load_html_response)
GEU20111660Y (en) Seknil tablet